Training Experience Required
- A significant training in medical oncology is required - being board certified would be a plus but is not mandatory.
- Some skills in French would make the training smoother, especially for clinical research fellowship (seeing patients included in clinical trials)
- M1 degree in Biology is the minimal requirement for the translational research fellow.
General Description
Institut Curie dates back to 1909, when Marie Curie implemented in the heart of Paris her bench-to-bedside vision of a research-care continuum. A leading player in the fight against cancer, the internationally renowned Institut Curie combines a Research Center and a Hospital Group that provides care for all types of cancers - including the rarest forms.
By embracing a crossdisciplinary approach, researchers and physicians develop together cancer-focused basic, translational and clinical research to discover more effective treatments and improve care for patients.
Expertise
- Breast cancer care
- Circulating tumor biomarkers (including ctDNA and CTC)
- Designing and setting up interventional trials based on biomarkers
Facilities
Institut Curie is the largest breast cancer center in France, with >4,000 new cases each year (7% of all breast cancer cases in France). The translational research fellowship would primarily take place in the laboratory of circulating biomarkers (located in Paris). This year would be devoted to setting up studies, performing wet lab experiments (under the guidance of the lab technicians), analyzing results and writing a paper. The translational research fellow will participate in several research programs. The laboratory has a (very) good publication track, yet the candidate must be self-motivated. The clinical research fellows will be part of the breast cancer clinical research unit (located in Saint Cloud, easily accessible by metro/train). Under the guidance of senior oncologists, he will acquire a solid training in clinical research, including studies on the most up-to-date drugs that are currently under development.
Last update: October 2019
